Bing Li (academic)
Bing Li | |
|---|---|
| Occupation(s) | Immunologist, researcher and academic |
| Academic background | |
| Education | Ph.D. in Immunology |
| Alma mater | Jiangsu University School of Medicine Southeast University School of Medicine Peking University Health Science Center |
| Academic work | |
| Institutions | University of Louisville University of Minnesota University of Iowa |
Bing Li is an immunologist, researcher, and academic. He is an endowed professor for Cancer Immunology, a professor of Pathology at the University of Iowa, and the director of Iowa Cancer and Obesity Initiative. He is also the founder of BMImmune Inc.
Li's research has focused on how FABP4 and FABP5 regulate metabolism and signaling in leukocytes. His work has linked FABPs to diseases like obesity, chronic inflammation, and cancer risk and development, while also identifying clinical applications through targeted FABP activity modification.
Li has been appointed as the University Scholar by the University of Louisville, Endowed Professor in Cancer Immunology Research by the University of Iowa and was featured as a Spotlight Investigator by Nutrition Frontiers, a publication of the Nutritional Science Research Group (NSRG), NCI, NIH. He serves as the guest editor of Tumor Microenvironment for the journal Cancers, and has been an Editorial Board Member for the Journal of Allergy, and BMC Immunology.